1.   

On 20 September 2019, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).

This notification concerns the following undertakings:

—	Lindsay & Co. LLC (USA) which belongs to Lindsay Goldberg group (‘Lindsay Goldberg’, USA), and

—	Bilcare Research Swiss I AG and (ii) Bilcare Research Swiss II AG (together with their subsidiaries ‘Bilcare Research Swiss Holding I and II’, Switzerland).

Linday Goldberg acquire within the meaning of Article 3(1)(b) of the Merger Regulation sole control of Bilcare Research Swiss Holding I and II.

The concentration is accomplished by way of purchase of shares.

2.   

The business activities of the undertakings concerned are:

—	Lindsay Goldberg indirectly manages different funds that hold equity investments in operating portfolio companies,

—	Bilcare Research Swiss Holding I and II is a manufacturer and supplier of technical plastic films that are used for the production of flexible packaging as well as for non-packaging applications.

3.   

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4.   

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.9500 — Lindsay Goldberg Group/Bilcare Research Swiss Holding I and II

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

Email: COMP-MERGER-REGISTRY@ec.europa.eu

Fax +32 22964301

Postal address:

European Commission

Directorate-General for Competition

Merger Registry

1049 Bruxelles/Brussel

BELGIQUE/BELGIË